<DOC>
	<DOC>NCT01202123</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of highly purified (HP) menotrophine to Korean women.</brief_summary>
	<brief_title>Post Marketing Surveillance of MENOPUR</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Anovulation in women (WHO group II) Controlled ovarian hyperstimulation cases for ART Hypersensitivity to MENOPUR Pregnancy, lactation or contraindication to pregnancy Ovarian cysts not related to polycystic ovarian syndrome Abnormal uterine bleeding Tumors in uterus, ovaries and breasts Ovarian hyperstimulation syndrome Thromboembolism or history of it Infertile due to other reason than anovulation High FSH level indication primary ovarian failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>